eFFECTOR Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update Nov 7, 2022 04:00PM
eFFECTOR Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update Nov 7, 2022 04:00PM
eFFECTOR Therapeutics (EFTR) Appoints Mayank Gandhi as Chief Business Officer Sep 26, 2022 08:01AM
eFFECTOR Therapeutics Appoints Mayank Gandhi, M.D., as Chief Business Officer Sep 26, 2022 08:00AM
eFFECTOR Therapeutics Appoints Mayank Gandhi, M.D., as Chief Business Officer Sep 26, 2022 08:00AM